Rimonabant Acomplia is a wonder diet pill manufactured by Sanofi Aventis for weight
loss treatment. Rimonabant Acomplia Zimulti has been approved by European Union in June 2006 and now has become the most popular treatment for weight loss in obese people. Rimonabant
Acomplia is also known as magic drug as it helps for smoking cessation as well as heart diseases. Rimonabant Acomplia was made marketable in the UK and rest of Europe as result of a conformity made by 25-member European Union. Acomplia is an anti –obesity with Rimonabant, as its main constituent. Rimonabant was discovered and manufactured by a French pharmaceutical firm, Sanofi-Aventis.
It works on the principle of targeting the CB-1 receptors, found in the Endo- cannabinoid (EC) system. These receptors control food and tobacco intake in the body. When these receptors are blocked, your appetite tends to reduce. As a result you eat less than your normal appetite and therefore you loose weight. It shows maximum results when used in addition with a low calorie diet and regular work out.
This diet drug
Acomplia Rimonabant reflects a few side effects, which go away once you get adjusted to the Acomplia treatment such as:
1. Dizziness
2. Muscle cramp
3. Sleep disorders
4. Nausea
5. Stomach upset
6. Diarrhea
Chantix stimulates the release of low levels of dopamine in your brain to help reduce the signs and symptoms of withdrawal. In addition, Chantix blocks nicotine receptors in your brain. So if you lapse and have a cigarette, your cigarette doesn't stimulate your brain's receptors the way it did in the past. Cigarettes become much less pleasurable, and your desire to return to regular smoking again may be reduced.
Chantix also appears to work better than the antidepressant bupropion, though results have been mixed. One study found that Chantix worked better for only the first 24 weeks. Others found Chantix worked better than bupropion for up to a year after participants quit smoking.
